Butabarbital will lessen the extent or outcome of fedratinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Result of coadministering a strong CYP3A4 inducer with fedratinib has not been examined. butabarbital will decrease the extent or influence of midazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. https://friedensreichy112yso6.bloggactivo.com/profile